We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP TIDMBAC
RNS Number : 4074G
GW Pharmaceuticals PLC
06 May 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES -------------------------------------------------------------------------------------- 1. Identity of the issuer or the underlying GW Pharmaceuticals plc issuer of existing shares to which voting rights are attached: ------------------------------------------------- ----------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ----------------------------------------------------------------------------- ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ----------------------------------------------------------------------------- ------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ----------------------------------------------------------------------------- ------- An event changing the breakdown of voting rights ----------------------------------------------------------------------------- ------- Other (please specify): ------------------ --------------------------------------------------------- ------- 3. Full name of person(s) subject Bank of America Corporation to the notification obligation: ------------------------------------------ ------------------------------------------ 4. Full name of shareholder(s) Merrill Lynch, Pierce, Fenner & Smith (if different from 3.): Incorporated Citadel LLC Bank of America Na ------------------------------------------ ------------------------------------------ 5. Date of the transaction and date 1(st) May 2014 on which the threshold is crossed or reached: ------------------------------------------ ------------------------------------------ 6. Date on which issuer notified: 6(th) May 2014 ------------------------------------------ ------------------------------------------ 7. Threshold(s) that is/are crossed Below notifiable threshold or reached: ------------------------------------------ ------------------------------------------ 8. Notified details: -------------------------------------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares -------------------------------------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ----------------- ---------------------------------- ------------------------------------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights Shares Voting Rights ----------------- -------------- ------------------ ------------------- -------------------------------- ------------------------------------------ Direct Direct Indirect Direct Indirect ----------------- ---- ------ ------ ----- --- ------------------- ------------------- ----------- --------------------- ------------------- 6,998,508 6,998,508 Below notifiable Below notifiable Below Below notifiable Below notifiable (583,209 (583,209 threshold threshold notifiable threshold threshold ADRS) ADRS) threshold GB0030544687 (US36197T1034) 1 ADR = 12 shares -------------- ------------------ ------------------- ------------------- ----------- --------------------- ------------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion Period rights that may rights be acquired if the instrument is exercised/ converted. ------------------------- -------------- --------------------------------------- ------------------------------------- ----------------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights instrument price date Conversion rights instrument period refers to ------------------- ------------ ------------- ------------------------ --------------------------------------- ----------------------------------- Nominal Delta ----------------- ------------ ------------- ------------------------ --------------------------------------- ------------------- -------------- N/A ------------------- ---- ------ ------ ----- --- ----------------- ------ ----------- ----------- ----- ------------------- -------------- Total (A+B+C) -------------------------------------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------------------------------ ------------------------------------------------------------------------------ Below notifiable threshold Below notifiable threshold ------------------------------------------------------------------------ ------------------------------------------------------------------------------ 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: -------------------------------------------------------------------------------- Merrill Lynch, Pierce, Fenner & Smith Incorporated - Below notifiable threshold Citadel LLC - Below notifiable threshold Bank of America Na - Below notifiable threshold Proxy Voting: -------------------------------------------------------------------------------- 10. Name of the proxy holder: --------------------------------------------------- --------------------------- 11. Number of voting rights proxy holder will cease to hold: --------------------------------------------------- --------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------------------------- --------------------------- 13. Additional information: ---------------------------------------- -------------------------------------- 14. Contact name: Szabina Biro ---------------------------------------- -------------------------------------- 15. Contact telephone number: 0207 996 5648 ---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAKSKESDLEFF
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions